OA demonstrates preventive and therapeutic effects on kidney diseases by modulating various signalling pathways, including NF- κB, STAT, PI3K/AKT, TLR4, and Nrf2/HO-1. This evidence concerns the gene NFE2L2 and kidney disorder.